Full-Body Cancer Screening: PET/CT vs. Full-body MRI – Which is Best?

Positron Emission Tomography (PET) and full-body MRI are two advanced imaging techniques used in cancer detection in Australia. While both offer significant diagnostic capabilities, their applications and suitability differ. This article explores their roles in full body cancer screening, particularly for asymptomatic individuals, and compares their effectiveness and safety to guide informed decisions.

What Is PET, and How Does It Detect Cancer?

PET scans are functional imaging tools that use a radioactive tracer, typically fluorodeoxyglucose (FDG), to detect areas of high metabolic activity. Cancer cells often exhibit increased glucose metabolism, allowing PET scans to highlight these abnormalities.

To improve accuracy, PET is usually combined with CT (computed tomography), which provides detailed anatomical images to pinpoint the location of abnormal metabolic activity. This combination—known as PET/CT—has proven effective for detecting known cancerous lesions, monitoring disease progression, and evaluating treatment response.

Is PET/CT Suitable for Cancer Screening in Asymptomatic Individuals?

While PET/CT is a powerful diagnostic tool in oncology, its use in routine cancer screening for asymptomatic individuals is controversial due to several limitations:

• Radiation Exposure
  A single full-body PET/CT scan exposes patients to approximately 25 millisieverts (mSv) of radiation (1). Even lower doses, around 10 mSv, have been linked to an increased lifetime risk of developing cancer. For individuals undergoing repeated scans over their lifetime, this cumulative radiation exposure could inadvertently contribute to the development of the very disease it aims to detect.
• Sensitivity
  PET sensitivity depends on radiotracer uptake, which some cancers may not exhibit, particularly if they are less metabolically active. For example, low-grade tumours or certain cancers like prostate cancer often require specific radiotracers, such as PSMA-based tracers, for effective detection. The choice of an appropriate radiotracer varies depending on the cancer type, making this modality less suitable for general screening.
• False Positives
  PET/CT can also detect areas of increased metabolic activity that are unrelated to cancer, such as infections, inflammation, or benign growths. 

What Is Full Body MRI, and How Does It Detect Cancer?

Full-body MRI offers a safer and more comprehensive alternative for cancer screening. Unlike PET, MRI does not use ionising radiation, making it an ideal option for routine use, particularly in asymptomatic individuals.

MRI employs strong magnetic fields and radiofrequency (RF) to create detailed images of the body. Instead of focusing on metabolic activity, MRI examines structural changes, tissue characteristics, and disruptions in tissue physiology (e.g. Diffusion Weighted Imaging), which are indicative of potential malignancies. 

Advantages of Full-Body MRI in Cancer Detection in Australia

1. No Radiation Exposure
   MRI eliminates the risks associated with ionising radiation, making it a safer choice for individuals seeking routine cancer screening or long-term health monitoring.
2. Detection of a Broad Range of Cancers
   MRI is particularly effective for identifying abnormalities in bone and soft tissues, including the brain, liver, and pancreas. It can detect changes that may signal the early stages of cancer, enabling prompt diagnosis and intervention.
3. Advanced Imaging Techniques
   Recent innovations, such as our proprietary geometrically corrected Diffusion-Weighted Imaging (DWI), enhance MRI’s sensitivity for detecting early-stage cancers. DWI identifies areas of restricted diffusion within tissues, a marker of abnormal cellular activity often associated with malignancy. At Whole Body MRI™, our exclusive 3T DWI technology achieves perfect distortion correction, ensuring unparalleled clarity and sensitivity. This advancement allows us to visualise early-stage cancers with greater accuracy than ever before. Visit our Scan webpage, to learn more about our imaging and reporting protocol.

Conclusion: Which Is Better for Cancer Screening in Asymptomatic Individuals?

For full-body cancer screening in asymptomatic individuals, full-body MRI offers clear advantages over PET/CT. While PET/CT remains a valuable tool for staging and monitoring cancer in symptomatic patients, its traditionally high radiation dose make it unsuitable for routine use in healthy individuals.

Full-body MRI, on the other hand, provides a safer, more comprehensive approach. By eliminating ionising radiation exposure and leveraging cutting-edge imaging techniques like geometrically corrected DWI, our 3T Whole Body MRI™ delivers unmatched accuracy and diagnostic confidence.

Book a Whole Body MRI Cancer Screening In Australia

Don’t wait for symptoms. Start your journey into the known today.

Contact us to learn more about Australia’s most advanced full body cancer screening technology.

Related Articles:

• Full Body MRI vs CT Scan for Cancer Screening
• What to Look For in a Whole-body MRI Provider
• Full Body MRI vs CT Scan for Cancer Screening
• The Importance of Diffusion Weighted Imaging
• How Much Does Full Body MRI Cost in Australia?
• Is Full Body MRI Worth It?

Author: A. Forbes, PhD

References

1. Brix G, Lechel U, Glatting G, et al. “Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.” Journal of Nuclear Medicine, vol. 46, no. 4, 2005.
2. Koh DM, Blackledge M, Padhani AR, et al. “Whole-body diffusion-weighted MRI: Tips, tricks, and pitfalls.” American Journal of Roentgenology, vol. 199, 2012.